Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Way I get to 50$ a share

<< Previous

Bullboard Posts

Next >>

Post by Marky1on Feb 12, 2021 8:15pm

332 Views

Post# 32559969

Way I get to 50$ a share

It was mentioned on a BioPUB conversation that there is a company out of Montreal...called Repare .
Therapeutics...RPTX...They are in a preclinical stage in their testing and they trade on Nasdaq.

Their MC is around 1.6 B$ CDN. they are In a " synthetic Lethality " research...As a med student, I ,

have no idea what that means...very sketchy. and obscure. The market that they are after is small.

Our drug is clear cut and the market we are going after is just HUGE. Thus I put our MC at a very

conservative true value of 2B$ CDN ...That's how I get 50$ a share. Probably worth a lot more than that
GLTA

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions